Böttcher, M., Lentini, S., Arens, E. R., Kaiser, A., van der Mey, D., Thuss, U., . . . Wensing, G. (2018). First‐in‐man–proof of concept study with molidustat: A novel selective oral HIF‐prolyl hydroxylase inhibitor for the treatment of renal anaemia. Br J Clin Pharmacol.
Citação norma ChicagoBöttcher, M., S. Lentini, E. R. Arens, A. Kaiser, D. van der Mey, U. Thuss, D. Kubitza, and G. Wensing. "First‐in‐man–proof of Concept Study With Molidustat: A Novel Selective Oral HIF‐prolyl Hydroxylase Inhibitor for the Treatment of Renal Anaemia." Br J Clin Pharmacol 2018.
MLA CitationBöttcher, M., et al. "First‐in‐man–proof of Concept Study With Molidustat: A Novel Selective Oral HIF‐prolyl Hydroxylase Inhibitor for the Treatment of Renal Anaemia." Br J Clin Pharmacol 2018.